[CYCC] YoY Quarter Result on 31-Dec-2013 [#Q4]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
26-Mar-2014
Financial Year
2013
Quarter
31-Dec-2013 [#Q4]
Profit Trend
QoQ- 28.88%
YoY- 25.29%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Revenue 277 424 247 299 5 175 138 12.30%
PBT -3,249 -3,872 -5,907 -4,026 -5,067 -3,780 -3,323 -0.37%
Tax -409 -498 -1,108 -452 -637 -122 -151 18.04%
NP -2,839 -3,374 -4,799 -3,559 -4,764 -3,658 -3,172 -1.82%
Tax Rate - - - - - - - -
Total Cost 3,116 3,798 5,046 3,858 4,769 3,833 3,310 -1.00%
Ratio Analysis
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
NP Margin -1,024.91 -795.75 -1,942.91 -1,190.30 -95,280.00 -2,090.29 -2,298.55 -12.58%
Per Share
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
EPS -13.34 -23.15 -50.11 -44.87 -149.01 -113.25 -115.84 -30.22%
EPS Diluted -13.34 -23.15 -50.11 -44.87 -149.01 -112.22 -114.43 -30.08%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.